17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Possible Adverse Effects of Food Additive E171 (Titanium Dioxide) Related to Particle Specific Human Toxicity, Including the Immune System

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Titanium dioxide (TiO 2) is used as a food additive (E171) and can be found in sauces, icings, and chewing gums, as well as in personal care products such as toothpaste and pharmaceutical tablets. Along with the ubiquitous presence of TiO 2 and recent insights into its potentially hazardous properties, there are concerns about its application in commercially available products. Especially the nano-sized particle fraction (<100 nm) of TiO 2 warrants a more detailed evaluation of potential adverse health effects after ingestion. A workshop organized by the Dutch Office for Risk Assessment and Research (BuRO) identified uncertainties and knowledge gaps regarding the gastrointestinal absorption of TiO 2, its distribution, the potential for accumulation, and induction of adverse health effects such as inflammation, DNA damage, and tumor promotion. This review aims to identify and evaluate recent toxicological studies on food-grade TiO 2 and nano-sized TiO 2 in ex-vivo, in-vitro, and in-vivo experiments along the gastrointestinal route, and to postulate an Adverse Outcome Pathway (AOP) following ingestion. Additionally, this review summarizes recommendations and outcomes of the expert meeting held by the BuRO in 2018, in order to contribute to the hazard identification and risk assessment process of ingested TiO 2.

          Related collections

          Most cited references173

          • Record: found
          • Abstract: found
          • Article: not found

          Mechanism and Regulation of NLRP3 Inflammasome Activation.

          Members of the nucleotide-binding domain and leucine-rich repeat (LRR)-containing (NLR) family and the pyrin and HIN domain (PYHIN) family can form multiprotein complexes termed 'inflammasomes'. The biochemical function of inflammasomes is to activate caspase-1, which leads to the maturation of interleukin 1 beta (IL-1β) and IL-18 and the induction of pyroptosis, a form of cell death. Unlike other inflammasomes, the NLRP3 inflammasome can be activated by diverse stimuli. The importance of the NLRP3 inflammasome in immunity and human diseases has been well documented, but the mechanism and regulation of its activation remain unclear. In this review we summarize current understanding of the mechanism and regulation of NLRP3 inflammasome activation as well as recent advances in the noncanonical and alternative inflammasome pathways.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            INFOGEST static in vitro simulation of gastrointestinal food digestion

            Developing a mechanistic understanding of the impact of food structure and composition on human health has increasingly involved simulating digestion in the upper gastrointestinal tract. These simulations have used a wide range of different conditions that often have very little physiological relevance, and this impedes the meaningful comparison of results. The standardized protocol presented here is based on an international consensus developed by the COST INFOGEST network. The method is designed to be used with standard laboratory equipment and requires limited experience to encourage a wide range of researchers to adopt it. It is a static digestion method that uses constant ratios of meal to digestive fluids and a constant pH for each step of digestion. This makes the method simple to use but not suitable for simulating digestion kinetics. Using this method, food samples are subjected to sequential oral, gastric and intestinal digestion while parameters such as electrolytes, enzymes, bile, dilution, pH and time of digestion are based on available physiological data. This amended and improved digestion method (INFOGEST 2.0) avoids challenges associated with the original method, such as the inclusion of the oral phase and the use of gastric lipase. The method can be used to assess the endpoints resulting from digestion of foods by analyzing the digestion products (e.g., peptides/amino acids, fatty acids, simple sugars) and evaluating the release of micronutrients from the food matrix. The whole protocol can be completed in ~7 d, including ~5 d required for the determination of enzyme activities.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors

              The NLRP3 inflammasome is a multimeric protein complex that initiates an inflammatory form of cell death and triggers the release of proinflammatory cytokines IL-1β and IL-18. The NLRP3 inflammasome has been implicated in a wide range of diseases, including Alzheimer’s disease, Prion diseases, type 2 diabetes, and some infectious diseases. It has been found that a variety of stimuli including danger-associated molecular patterns (DAMPs, such as silica and uric acid crystals) and pathogen-associated molecular patterns (PAMPs) can activate NLRP3 inflammasome, but the specific regulatory mechanisms of NLRP3 inflammasome activation remain unclear. Understanding the mechanisms of NLRP3 activation will enable the development of its specific inhibitors to treat NLRP3-related diseases. In this review, we summarize current understanding of the regulatory mechanisms of NLRP3 inflammasome activation as well as inhibitors that specifically and directly target NLRP3.
                Bookmark

                Author and article information

                Journal
                Int J Mol Sci
                Int J Mol Sci
                ijms
                International Journal of Molecular Sciences
                MDPI
                1422-0067
                28 December 2020
                January 2021
                : 22
                : 1
                : 207
                Affiliations
                [1 ]Department of Toxicogenomics, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, P.O. Box 616, 6200 MD Maastricht, The Netherlands; t.dekok@ 123456maastrichtuniversity.nl (T.M.d.K.); dick.sijm@ 123456maastrichtuniversity.nl (D.T.H.M.S.); s.vanbreda@ 123456maastrichtuniversity.nl (S.G.v.B.); j.briede@ 123456maastrichtuniversity.nl (J.J.B.)
                [2 ]Netherlands Food and Consumer Product Safety Authority, P.O. Box 43006, 3540 AA Utrecht, The Netherlands; j.j.m.castenmiller@ 123456nvwa.nl (J.J.M.C.); a.opperhuizen@ 123456nvwa.nl (A.O.); henk.van.loveren@ 123456gmail.com (H.v.L.)
                [3 ]Unidad de Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autonóma de México, Mexico City 54090, Mexico; irasemachirino@ 123456gmail.com
                [4 ]Norwegian Institute of Public Health, P.O. Box 222 Skøyen, 0213 Oslo, Norway; hubert.Dirven@ 123456fhi.no
                [5 ]Food Standard Agency, London SW1H9EX, UK; dmgott@ 123456btinternet.com
                [6 ]French National Research Institute for Agriculture, Food and Environment (INRAE), 75338 Paris, France; eric.houdeau@ 123456inrae.fr
                [7 ]National Institute for Public Health and the Environment, P.O. Box 1, 3720 BA Bilthoven, The Netherlands; agnes.oomen@ 123456rivm.nl
                [8 ]National Food Institute, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark; morp@ 123456food.dtu.dk
                [9 ]Department of Gastroenterology and Hepatology, University Hospital of Zurich, 8091 Zurich, Switzerland; Gerhard.Rogler@ 123456usz.ch
                Author notes
                Author information
                https://orcid.org/0000-0001-5032-6314
                https://orcid.org/0000-0003-1421-8214
                https://orcid.org/0000-0003-1405-5232
                https://orcid.org/0000-0001-6627-3392
                Article
                ijms-22-00207
                10.3390/ijms22010207
                7795714
                33379217
                022d47d3-1e47-4723-892c-8716be94ba72
                © 2020 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 03 December 2020
                : 24 December 2020
                Categories
                Review

                Molecular biology
                titanium dioxide,tio2,e171,food additive,food safety,nanomaterial,nano size,oral exposure,mode of action,adverse health effects,toxicity,review

                Comments

                Comment on this article